CLINICAL_TRIALS
trial_result
· 2015-11-02
Clinical Trial Update: Efficacy of Prednisone In the Treatment of Ocular Myasthenia [Phase 3]
Summary
A Phase 3 trial evaluating prednisone for ocular myasthenia gravis was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Michael Benatar | Conditions: Ocular Myasthenia Gravis | Phase 3 | Status: TERMINATED | Results posted: 2015-11-02